1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Hypercalcemia: new trials by email Literature Review of Hypercalcemia trials Research Report on Hypercalcemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension - Idiopathic Infantile Hypercalcemia - Mild Form | Phase 1 | Unknown | The Hospital for Sick Children | 5 | 2018-02-22 | 2021-08-31 |
| Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients Cinacalcet HCl - Secondary Hyperparathyroidism, Hypercalcemia | Phase 1 / Phase 2 | Terminated | Montefiore Medical Center | 4 | 2007-02-09 | 2025-04-29 |
| An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer CAL - Breast Neoplasms, Breast Cancer | Phase 1 | Completed | Chugai Pharma USA | 2005-06-24 |
Breast Neoplasms (1) · Hypercalciuria (1) · Hyperparathyroidism, Secondary (1) · Neoplasm Metastasis (1) · Nephrocalcinosis (1)
Calcium Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Water-Electrolyte Imbalance (3) · Pathological Conditions, Signs and Symptoms (2) · Breast Diseases (1) · Calcinosis (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hyperparathyroidism (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
Cinacalcet (1) · Rifampin (1) · Suspensions (1)
Chugai Pharma USA (1) · Montefiore Medical Center (1) · The Hospital for Sick Children (1)
United States (2) · Canada (1)
Etienne Sochett, MD (1) · Maria Coco, MD, MS (1)